• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Hookipa Pharma Inc (NQ: HOOK )

    3.760 -0.080 (-2.08%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Hookipa Pharma Inc

    < Previous 1 2 3 4 5 6 7 8 Next >
    HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Beats Revenue for Q4 2023
    HOOK stock results show that HOOKIPA Pharma missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    HOOKIPA Pharma: Q4 Earnings Insights
    Via Benzinga
    HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
    From HOOKIPA Pharma Inc.
    Via GlobeNewswire
    HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
    From HOOKIPA Pharma Inc.
    Via GlobeNewswire
    Earnings Preview For HOOKIPA Pharma
    Via Benzinga
    Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
    Repare Therapeutics regains global rights to camonsertib (RP-3500) after terminating collaboration with Roche. $40M milestone achieved. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
    HOOKIPA Pharma's strategic focus on HB-200 program for HPV16+ HNSCC, infectious disease cure collaboration with Gilead, and recent developments. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
    From HOOKIPA Pharma Inc.
    Via GlobeNewswire
    AbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC's 'Final Trades'
    On CNBC’s "Halftime Report Final Trades," Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc. 
    Via Benzinga
    HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
    From HOOKIPA Pharma Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
    Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. 
    Via Benzinga
    Nasdaq Gains 100 Points; CarMax Earnings Top Views
    U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.37% to 37,218.15 while the NASDAQ rose 0.73% to 14,885.76.... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Crude Oil Moves Lower; Micron Issues Strong Forecast
    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.58% to 37,296.40 while the NASDAQ rose 0.77% to 14,891.87. The... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today?
    Gilead Sciences Inc (NASDAQ: GILD) announced on Thursday that it has purchased 15 million shares of HOOKIPA Pharma Inc (NASDAQ: HOOK) for approximately $21.25 million,  
    Via Benzinga
    Dow Jumps 250 Points; US Weekly Jobless Claims Edge Higher
    U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday. Following the market opening Thursday, the Dow traded up 0.72% to 37,348.90 while the NASDAQ rose 0.96%... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Polished.com (POL) Stock Down 38% Today?
    Polished.com stock is falling on Thursday as investors in POL react to the company's shares undergoing an extreme rally on Wednesday! 
    Via InvestorPlace
    Why Is Brenmiller Energy (BNRG) Stock Up Today?
    Brenmiller Energy stock is rising on Thursday as investors celebrate shares of BNRG regaining compliance with listing standards. 
    Via InvestorPlace
    Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?
    Hookipa Pharma stock is rising higher on Thursday as investors react to a purchase agreement for 15 million shares of HOOK. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! 
    Via InvestorPlace
    HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
    From HOOKIPA Pharma Inc.
    Via GlobeNewswire
    HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus
    From HOOKIPA Pharma Inc.
    Via GlobeNewswire
    HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
    From HOOKIPA Pharma Inc.
    Via GlobeNewswire
    HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023
    From HOOKIPA Pharma Inc.
    Via GlobeNewswire
    HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023
    From HOOKIPA Pharma Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.